Skip to main navigation Skip to search Skip to main content

Viral rebound after switch to maraviroc/raltegravir dual therapy in highly experienced and virologically suppressed patients with HIV-1 infection

  • S Nozza
  • , A Bigoloni
  • , Andrea CALCAGNO
  • , L Galli
  • , Pignataro AR
  • , ANTONIO D'AVOLIO
  • , A Carbone
  • , M Ripa
  • , Stefano BONORA
  • , A Lazzarin
  • , A. Castagna

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1436-1439
Number of pages4
JournalJournal of Antimicrobial Chemotherapy
Volume69
Issue number5
DOIs
Publication statusPublished - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this